Source:
https://revistaforum.com.br/saude/2...s-aumentam-em-mais-de-700-em-um-ms-no-brasil- 122149.html
Monkeypox cases increase by more than 700% in one month in Brazil
States already register infections among babies and there is also progress among young people and women
by Marcelo Hailer
Written in HEALTH on 8/24/2022 · 12:25 pm
share this article
The cases of smallpox of monkeys are on the rise in Brazil and register an increase of 767.7% of confirmed patients in the last month. With this, the country is the 3rd in the world with the highest number of cases.
Until July 20, the Ministry of Health recorded 449 confirmed cases, but the balance presented by the ministry on Tuesday (23) shows that the country has 3,896 people infected with smallpox.
With the spread of monkeypox, the age group of infected people also increased, which was previously concentrated among adult men. The states of São Paulo and Bahia recorded infection among babies under one year of age.
According to the Municipal Health Department of São Paulo, one of the patients is only ten months old and presented symptoms on the 11th. According to the folder, the baby's clinical condition is stable and he is in home isolation.
The other baby infected with monkeypox is from the city of Conceição do Jacuípe, in the interior of Bahia. He is two months old and showed symptoms on the last day 5.
Another group that begins to show an increase in cases is that of women, which increased from 1.4% to 6.8%.
The age range of most patients with monkeypox has also changed and today it affects people aged between 20 and 29 years, this group represents 44.2% of all cases.
In turn, the group of people aged between 30 and 39 years, which previously represented the majority of cases, now represent 19.9%.
Anvisa authorizes importation of medicines and vaccine without registrations in Brazil
The National Health Surveillance Agency (Anvisa) authorized last Friday (19) the importation of medicines and vaccines against monkeypox (monkeypox) without records in Brazil. The measure is exceptional and temporary.
Anvisa emphasizes that it does not actually exempt registration, but establishes a method to authorize products to combat monkeypox more quickly. The entire management of the agency voted in favor of the measure.
In practice, the measure allows the Ministry of Health to request the Agency to waive registration of drugs and vaccines that have already been approved by international agencies. The measure also simplifies the analysis of documents and facilitates the population's access to medicines and/or vaccines.
It was also established that the Ministry of Health will be responsible for defining the vulnerable and priority groups for the use of the drug or vaccine, as well as promoting the monitoring of imported drugs or vaccines and managing the guidelines for reporting adverse events and technical complaints and the guidelines for health services. .
The director-president of Anvisa, Antonio Barra Torres, declared that "the exemption from registration is a regulatory procedure, it is not to stop regulating, nor stop acting".
The measure takes effect as soon as it is published in the Official Gazette, which should take place this Friday in an extra edition.